ĐÁNH GIÁ CHẤT LƯỢNG CUỘC SỐNG CỦA BỆNH NHÂN ĐÁI THÁO ĐƯỜNG TÝP 2 ĐANG ĐIỀU TRỊ INSULIN TẠI KHOA KHÁM BỆNH CÁN BỘ CAO CẤP BỆNH VIỆN TWQĐ 108

Abstract

Objective: Assessment of quality of life in insulin-treated patients with type 2 diabetes at the Department of Health Care Senior Staff in the 108 Central Military Hospital. Subjects and methods: A cross-sectional descriptive study in 136 outpatients with type 2 diabetes and the insulin-treated at the medical examination department for senior staff - 108 Central Hospital from 10/2022 to 3/2023. Results: The average age of the patients was 67,3 ± 15,3; The time of diagnosis with type 2 diabetes from 6-10 years is the highest rate (39,5%); and starting insulin injection 1 - 5 years (41,9%). The rate of symptomatic hypoglycemia was from mild to severe (19,8%); the lipodystrophy (22%), two patients had an infection at the injection site (2%). The EQ-5D-5L score of the study was 0,79 ± 0,12, in which the characteristics of pain and discomfort accounted for the highest level of discomfort. There is a moderate correlation between chronic renal failure and EQ-5D-5L score (r = 0,58, p< 0,05) and stroke (r = 0,43, p< 0,05). There was a moderate correlation between the side effects of hypoglycemia with EQ-5D-5L score (r = 0,54, p< 0,05); and a weak correlation between allergy, itching, and redness with EQ-5D-5L score (r = 0,32, p< 0,05). Conclusion: The EQ-5D-5L questionnaire was related to important patient criteria such as side effects, complications, and co-morbidities such as stroke, hypoglycemia and allergies, itching, and redness. Therefore, in clinical practice, we can regularly evaluate the quality of life according to the EQ-5D-5L questionnaire to have appropriate interventional counseling solutions for patients.